Literature DB >> 29391673

Salivary and Serum Antioxidants in Women with Preeclampsia with or Without Periodontal Disease.

Mamatha S Shetty1, Amitha Ramesh1, Prasanna Kumar Shetty2, Priyanka Agumbe1.   

Abstract

Background and
Objectives: Preeclampsia is a challenging disease of human pregnancy that affects the mother and her foetus. It is a common obstetric syndrome of undefined aetiology affecting 7-10% of pregnant women. This study aimed to investigate the total antioxidant capacity (TAC), superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities, malondialdehyde levels, uric acid, vitamin C, and vitamin E levels in serum and saliva of preeclamptic and normotensive pregnant women with and without periodontitis.
Methods: Sixty pregnant women, divided into four groups, preeclamptic women with and without periodontitis, and normotensive pregnant women with and without periodontitis, were recruited between 26 and 36 weeks of gestation from the Outpatient Department of Obstetrics and Gynaecology, KS Hedge Hospital, Mangalore. Pocket depth, clinical attachment loss, and gingival index were measured in all subjects. Saliva and serum levels of TAC, SOD, and GPx activities, malondialdehyde levels, vitamin C, vitamin E, uric acid were determined using spectrophotometer.
Results: Comparison of sociodemographic variables among the study groups showed no significant differences. Salivary malondialdehyde levels were highest (p = 0.025), levels of antioxidants vitamin C (p = 0.027) and uric acid (p = 0.013) being significantly lower in preeclamptic women with periodontitis. This group also had significantly lower serum levels of vitamin C (p = 0.041) and SOD (p = 0.004). Conclusions: The results of our study show that periodontal disease may be potential risk factor for severity, progression, and even initiation of preeclampsia because of reduced antioxidant capacity or increased oxidative stress.

Entities:  

Keywords:  Antioxidants; Periodontitis; Preeclampsia

Year:  2017        PMID: 29391673      PMCID: PMC5783910          DOI: 10.1007/s13224-017-0993-4

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  17 in total

1.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION.

Authors:  J SILNESS; H LOE
Journal:  Acta Odontol Scand       Date:  1964-02       Impact factor: 2.331

2.  Association of Some Vitamins and Minerals with Periodontitis in a Nationally Representative Sample of Korean Young Adults.

Authors:  Ji-A Park; Jung-Hwa Lee; Hyo-Jin Lee; Bo-Hyoung Jin; Kwang-Hak Bae
Journal:  Biol Trace Elem Res       Date:  2016-12-29       Impact factor: 3.738

3.  Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy.

Authors:  D Wei; X-L Zhang; Y-Z Wang; C-X Yang; G Chen
Journal:  Aust Dent J       Date:  2010-03       Impact factor: 2.291

4.  Vitamin C in plasma and leucocytes in relation to periodontitis.

Authors:  Denica Kuzmanova; Ineke D C Jansen; Ton Schoenmaker; Kamran Nazmi; Wijnand J Teeuw; Sergio Bizzarro; Bruno G Loos; Ubele van der Velden
Journal:  J Clin Periodontol       Date:  2012-07-30       Impact factor: 8.728

5.  Local and systemic total antioxidant capacity in periodontitis and health.

Authors:  G R Brock; C J Butterworth; J B Matthews; I L C Chapple
Journal:  J Clin Periodontol       Date:  2004-07       Impact factor: 8.728

6.  Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis.

Authors:  Ferda Alev Akalin; Esra Baltacioğlu; Ahmet Alver; Erdem Karabulut
Journal:  J Clin Periodontol       Date:  2007-07       Impact factor: 8.728

7.  Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in pregnant women with chronic periodontitis.

Authors:  Ferda Alev Akalin; Esra Baltacioğlu; Ahmet Alver; Erdem Karabulut
Journal:  J Periodontol       Date:  2009-03       Impact factor: 6.993

8.  Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients.

Authors:  Cenk Fatih Canakci; Yasin Cicek; Abdulkadir Yildirim; Ufuk Sezer; Varol Canakci
Journal:  Eur J Dent       Date:  2009-04

9.  Antioxidant therapy as monotherapy or as an adjunct to treatment of periodontal diseases.

Authors:  Aditi Mathur; Lalit Mathur; Balaji Manohar; Hemant Mathur; Rajesh Shankarapillai; Neema Shetty; Aman Bhatia
Journal:  J Indian Soc Periodontol       Date:  2013-01

Review 10.  The antioxidant master glutathione and periodontal health.

Authors:  Vivek Kumar Bains; Rhythm Bains
Journal:  Dent Res J (Isfahan)       Date:  2015 Sep-Oct
View more
  4 in total

1.  Assessment of Levels of Plasma Oxidative Stress in Patient Having Aggressive Periodontitis before and after Full Mouth Disinfection.

Authors:  Sachin Bhagat; Parthivi Singh; Anuj Singh Parihar; Gurpreet Kaur; Harsh Takkar; Rathi Rela
Journal:  J Pharm Bioallied Sci       Date:  2021-06-05

2.  Oxidative Stress Markers Differ in Two Placental Dysfunction Pathologies: Pregnancy-Induced Hypertension and Intrauterine Growth Restriction.

Authors:  Aleksandra Zygula; Przemyslaw Kosinski; Piotr Wroczynski; Magdalena Makarewicz-Wujec; Bronislawa Pietrzak; Mirosław Wielgos; Joanna Giebultowicz
Journal:  Oxid Med Cell Longev       Date:  2020-06-30       Impact factor: 6.543

3.  Placental endothelial nitric oxide synthase expression and role of oxidative stress in susceptibility to preeclampsia in Pakistani women.

Authors:  Ghazala Shaheen; Sarwat Jahan; Qurat Ul Ain; Asad Ullah; Tayyaba Afsar; Ali Almajwal; Iftikhar Alam; Suhail Razak
Journal:  Mol Genet Genomic Med       Date:  2019-11-08       Impact factor: 2.183

4.  Characterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy Women.

Authors:  Jenna L Riis; Stephanie H Cook; Nicole Letourneau; Tavis Campbell; Douglas A Granger; Gerald F Giesbrecht
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.